Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Comprehensive Cancer Center, University of Virginia Health, Charlottesville, Virginia.
Clin Obstet Gynecol. 2024 Dec 1;67(4):660-665. doi: 10.1097/GRF.0000000000000894. Epub 2024 Oct 7.
Hereditary cancer syndromes (HCS) are responsible for up to 10% of all cancers. At present, the majority of cancer susceptibility testing is initiated after a cancer diagnosis. There exists a significant opportunity for primary care providers including general obstetrician-gynecologists to engage in hereditary cancer risk assessment through adequate family history evaluation, initiation of genetic testing, and following the recommendations of national organizations. Identifying hereditary cancer genes may prompt primary prevention efforts such as enhanced screening, prevention, or personalized care strategies. We will review the literature regarding the approach and assessment of the most common gynecologic HCS.
遗传性癌症综合征(HCS)占所有癌症的 10%左右。目前,大多数癌症易感性测试是在癌症诊断后启动的。包括普通妇产科医生在内的初级保健提供者有很大的机会通过充分的家族史评估、遗传测试的启动以及遵循国家组织的建议来进行遗传性癌症风险评估。确定遗传性癌症基因可能会促使采取初级预防措施,如增强筛查、预防或个性化护理策略。我们将回顾关于最常见妇科 HCS 的方法和评估的文献。